Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New entries appear in the Record History, reflecting updated version dates and status changes for the study (including status and contacts/locations updates). These are administrative changes and do not alter the study data.
    Difference
    0.0%
    Check dated 2025-10-27T20:54:46.000Z thumbnail image
  3. Check
    30 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:12:15.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Page updates include a new revision (v3.1.0), a new study status/locations entry dated 2025-09-19, and a current date marker (2025-09-22), with removal of the older v3.0.2. This signals ongoing content and metadata updates rather than changes to core products or schedules.
    Difference
    0.3%
    Check dated 2025-09-29T04:39:52.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Updated version to v3.0.2 and removed the 'Back to Top' link; no other substantial content changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T22:08:45.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new revision version (v3.0.1) and has removed an older date (2025-08-13).
    Difference
    0.5%
    Check dated 2025-09-07T19:10:41.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings. These changes enhance the clarity and relevance of the page's content.
    Difference
    100%
    Check dated 2025-08-31T12:21:41.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.